PARTNER N°

5

NAME OF INSTITUTION

Leiden University Medical Center

BRIEF DESCRIPTION OF THE TEAM

 

Leiden University Medical Center, department of Medical Microbiology

The LUMC (7000 employees,  >700 million turnover) is an internationally renowned biomedical research institute. The Molecular Virology team, headed by Prof. Eric Snijder, is among the world leaders in studying the molecular biology of +RNA virus replication and virus-host interactions (over 200 papers published) and uses this knowledge to develop novel antiviral strategies, with a special focus on corona-, alpha-, and flaviviruses, including ZIKV. There is extensive experience in development of research tools for various +RNA viruses, including virus culture, reverse genetics technology, biosafe systems (replicons), biochemical assays, protein-RNA interaction studies, advanced light and electron microscopy, functional genomics (siRNA, shRNA, CRISPR/Cas) and proteomics screening of infected cells. The Department is fully equipped for molecular virological, biochemical and antiviral studies, and includes several BSL-2 labs and a state-of-the-art BSL-3 facility with the possibility to use radioactive isotopes (for MoA studies) and automation for medium-throughput screens. The diagnostics section and collaboration with the Department of Infectious Disease (special interest in travel-related infections) provides access to a large collection of clinical samples, including panels of control sera. The group of prof. Gorbalenya has state-of-the-art bioinformatics facilities, including in-house developed software platforms (e.g. VIRALIS) for virus bioinformatics studies.

 

KEY CONTACT PERSON(S)

Key scientific contact person 1 (Team leader)

Name

Dr. Martijn van Hemert

Photo

 

Position in the Institution

Principal Investigator

Email address

M.J.van_Hemert@lumc.nl

Phone number

 

+31 71 5266793

Mobile phone number

 

Postal address

Dr. M.J. van Hemert

Department of Medical Microbiology

Leiden University Medical Center

Albinusdreef 2

2333 ZA Leiden

The Netherlands

 

Role in the Consortium

WP3 (co-leader)

Task: 1, 3, & 4

Sub-task: 1.1, 1.2, 1.3, 3.1, 3.2, 3.3 & 4.3

Role: WP3 co-leader ; Task 1 leader ; Subtask 1.2 leader ; Task 1.1, 1.2, 1.3, 3.1, 3.2, 3.3, and 4.3 contributor

Analysis of the mechanisms of infection and characterization of the replication cycle of ZIKV in cell culture, including the identification of host factors involved in ZIKV infection and elucidation of their role in replication. Development of a ZIKV tool box aimed at providing ZIKV-specific assays, materials, protocols etc to other tasks and WPs, e.g. to support development of diagnostics or perform mode-of-action studies on antiviral compounds. This includes reverse genetics systems (including biosafe systems and reporter viruses), cell culture models and panels of ZIKV isolates. Molecular virological studies to elucidate the mode of action of compounds with anti-ZIKV activity identified by other partners within WP3.